Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Leigh Perreault

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prediabetic State
23
2023
224
7.040
Why?
Diabetes Mellitus, Type 2
47
2023
2098
5.320
Why?
Hypoglycemic Agents
23
2023
1006
3.690
Why?
Insulin Resistance
29
2023
1077
3.550
Why?
Blood Glucose
31
2023
1821
2.890
Why?
Obesity
25
2023
2524
2.820
Why?
Weight Loss
13
2023
641
2.340
Why?
Cardiovascular Diseases
15
2020
1729
2.260
Why?
Muscle, Skeletal
19
2023
1477
2.170
Why?
Insulin
19
2023
2082
2.040
Why?
Diabetes Mellitus
11
2023
906
1.770
Why?
Sphingolipids
6
2023
58
1.720
Why?
Benzhydryl Compounds
3
2017
60
1.530
Why?
Glucose Intolerance
8
2020
137
1.510
Why?
Diabetic Angiopathies
3
2017
244
1.490
Why?
Triglycerides
10
2022
471
1.470
Why?
Overweight
7
2022
474
1.220
Why?
Diabetes Complications
2
2019
212
1.160
Why?
Diglycerides
5
2020
55
1.130
Why?
Glucosides
2
2017
36
1.130
Why?
Glucagon-Like Peptide 1
3
2023
100
1.070
Why?
Life Style
12
2020
431
1.060
Why?
Primary Health Care
6
2023
1512
0.990
Why?
Metformin
13
2023
278
0.970
Why?
Receptors, Gastrointestinal Hormone
1
2023
5
0.910
Why?
Glucose Tolerance Test
15
2021
344
0.890
Why?
Exercise
10
2017
1644
0.880
Why?
Anti-Obesity Agents
1
2023
45
0.840
Why?
Goals
2
2021
152
0.840
Why?
Humans
90
2023
115047
0.830
Why?
Adult
50
2023
30658
0.820
Why?
Health Equity
1
2023
53
0.810
Why?
Middle Aged
41
2023
26830
0.790
Why?
Liver
4
2014
1681
0.780
Why?
Nutrition Therapy
1
2022
31
0.780
Why?
Glucose Clamp Technique
9
2021
181
0.730
Why?
Adipose Tissue
4
2023
558
0.730
Why?
Hyperglycemia
4
2014
293
0.710
Why?
Primary Care Nursing
1
2019
3
0.690
Why?
Male
55
2023
55735
0.670
Why?
Female
60
2023
59617
0.670
Why?
Microvessels
1
2019
68
0.640
Why?
Insulin, Long-Acting
1
2019
52
0.630
Why?
Peripheral Vascular Diseases
1
2019
98
0.630
Why?
Obesity Management
1
2018
8
0.630
Why?
Body Mass Index
11
2023
1967
0.620
Why?
Glucagon-Like Peptide-1 Receptor
1
2019
71
0.620
Why?
Infant, Newborn, Diseases
1
2019
104
0.610
Why?
Awareness
1
2019
92
0.610
Why?
Fasting
4
2020
242
0.600
Why?
Risk Factors
19
2023
8642
0.590
Why?
Precision Medicine
1
2021
340
0.590
Why?
Weight Reduction Programs
2
2017
94
0.570
Why?
Policy
1
2018
138
0.570
Why?
Incretins
2
2021
15
0.550
Why?
Risk Management
1
2017
89
0.550
Why?
Rest
2
2017
105
0.540
Why?
Choristoma
1
2015
23
0.510
Why?
Sleep Deprivation
5
2021
166
0.510
Why?
Insulin-Secreting Cells
2
2010
318
0.500
Why?
Weight Gain
4
2019
451
0.470
Why?
Lipid Metabolism
4
2021
449
0.450
Why?
Randomized Controlled Trials as Topic
4
2022
1215
0.440
Why?
Glucose
4
2023
900
0.430
Why?
Clinical Trials as Topic
1
2017
937
0.430
Why?
Phenols
1
2013
82
0.420
Why?
Glucagon-Like Peptides
2
2022
22
0.390
Why?
Physical Endurance
5
2020
231
0.390
Why?
Aged
17
2023
19122
0.370
Why?
Fenofibrate
1
2011
24
0.370
Why?
Hospitalization
1
2019
1755
0.370
Why?
Hypolipidemic Agents
1
2011
87
0.350
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2010
43
0.350
Why?
Palmitates
1
2009
16
0.350
Why?
Pyrazines
1
2010
71
0.350
Why?
Biomarkers
8
2023
3419
0.330
Why?
Energy Metabolism
4
2021
729
0.330
Why?
Sleep
4
2021
631
0.330
Why?
Athletes
6
2020
324
0.330
Why?
Triazoles
1
2010
130
0.330
Why?
Cross-Sectional Studies
7
2023
4411
0.310
Why?
Sex Characteristics
3
2021
635
0.290
Why?
Ceramides
3
2022
94
0.290
Why?
Diabetic Nephropathies
2
2020
234
0.290
Why?
Risk Reduction Behavior
3
2023
201
0.290
Why?
Sodium-Glucose Transporter 2
2
2017
17
0.290
Why?
Sex Factors
5
2018
1721
0.280
Why?
Absenteeism
2
2018
40
0.280
Why?
Markov Chains
2
2018
114
0.270
Why?
Health Services
2
2018
103
0.260
Why?
Renal Insufficiency, Chronic
2
2022
486
0.260
Why?
Pilot Projects
2
2021
1375
0.260
Why?
Adiponectin
3
2018
212
0.260
Why?
Circadian Rhythm
3
2019
354
0.260
Why?
Follow-Up Studies
6
2021
4420
0.260
Why?
Lipids
3
2015
586
0.250
Why?
Remission Induction
3
2019
233
0.250
Why?
Young Adult
11
2019
10498
0.240
Why?
Double-Blind Method
4
2022
1665
0.240
Why?
Dietary Fats
3
2020
290
0.230
Why?
Lipogenesis
2
2017
57
0.230
Why?
Lipoprotein Lipase
1
2004
54
0.220
Why?
Consensus
3
2020
534
0.210
Why?
Socioeconomic Factors
2
2018
1081
0.210
Why?
Healthy Lifestyle
1
2023
29
0.210
Why?
Computer Simulation
2
2018
881
0.210
Why?
Physical Exertion
1
2004
211
0.210
Why?
Energy Intake
4
2021
421
0.210
Why?
Diet, Reducing
3
2017
79
0.200
Why?
Prevalence
2
2019
2255
0.200
Why?
Combined Modality Therapy
4
2019
1127
0.200
Why?
Biopsy
3
2018
1046
0.200
Why?
Sarcolemma
2
2020
29
0.200
Why?
Cluster Analysis
1
2023
458
0.190
Why?
Endpoint Determination
2
2019
69
0.190
Why?
Muscle Fibers, Skeletal
2
2023
185
0.190
Why?
Nephrology
1
2022
48
0.190
Why?
Glucose Transporter Type 4
1
2021
36
0.190
Why?
Cytosol
2
2020
208
0.190
Why?
Ambulatory Care Facilities
1
2023
211
0.180
Why?
Carnitine
1
2021
62
0.180
Why?
Risk Adjustment
1
2020
75
0.180
Why?
Oxidation-Reduction
3
2021
926
0.170
Why?
Endocrinologists
1
2020
12
0.170
Why?
New Zealand
1
2019
41
0.170
Why?
Pragmatic Clinical Trials as Topic
1
2019
48
0.170
Why?
Endoplasmic Reticulum
2
2020
234
0.170
Why?
Cytosine
1
2019
44
0.170
Why?
Adolescent
8
2023
17864
0.160
Why?
Fatty Liver
1
2021
217
0.160
Why?
United States
9
2023
12227
0.160
Why?
Exercise Test
3
2015
545
0.160
Why?
Liraglutide
1
2019
27
0.160
Why?
Fatty Acids, Nonesterified
2
2019
151
0.160
Why?
Retinal Diseases
1
2019
76
0.160
Why?
Models, Econometric
1
2018
34
0.160
Why?
Referral and Consultation
1
2023
633
0.160
Why?
Colorado
3
2023
4089
0.150
Why?
Postprandial Period
1
2019
88
0.150
Why?
Quinolizines
1
1997
4
0.150
Why?
Drug Combinations
1
2019
287
0.150
Why?
Dose-Response Relationship, Drug
2
2019
1857
0.150
Why?
Antiemetics
1
1997
32
0.150
Why?
Nausea
1
1997
102
0.140
Why?
Severity of Illness Index
2
2018
2551
0.140
Why?
Cholesterol, HDL
2
2015
184
0.140
Why?
Health Resources
1
2018
122
0.140
Why?
Vomiting
1
1997
124
0.140
Why?
Tissue Plasminogen Activator
2
2018
227
0.140
Why?
Hysterectomy
1
1997
106
0.140
Why?
Surgical Wound Infection
1
2019
247
0.140
Why?
Odds Ratio
1
2019
957
0.140
Why?
Treatment Outcome
6
2021
9123
0.140
Why?
Body Weight
3
2015
873
0.130
Why?
Patient Participation
1
2019
360
0.130
Why?
Patient-Centered Care
1
2021
474
0.130
Why?
Delivery of Health Care
1
2023
835
0.130
Why?
Research Design
2
2019
930
0.130
Why?
Exercise Therapy
2
2017
351
0.130
Why?
Phosphatidylethanolamines
1
2016
66
0.130
Why?
Eating
2
2021
347
0.130
Why?
Kidney Diseases
1
2019
350
0.130
Why?
Blotting, Western
2
2016
1149
0.130
Why?
Cost-Benefit Analysis
1
2018
544
0.130
Why?
Indoles
1
1997
304
0.130
Why?
Phosphatidylcholines
1
2016
133
0.130
Why?
Qualitative Research
1
2019
935
0.120
Why?
Patient Compliance
1
2019
524
0.120
Why?
Costs and Cost Analysis
1
2015
196
0.120
Why?
Hypoglycemia
1
2019
385
0.120
Why?
Sleep Apnea Syndromes
1
2015
74
0.120
Why?
Income
1
2015
167
0.120
Why?
Logistic Models
1
2019
1839
0.120
Why?
Health Personnel
1
2019
574
0.120
Why?
Pneumonia
1
2019
568
0.120
Why?
Somatostatin
1
2014
52
0.120
Why?
Employment
1
2015
139
0.110
Why?
Recovery of Function
2
2015
575
0.110
Why?
Smoking
2
2012
1392
0.110
Why?
Fructose
1
2014
100
0.110
Why?
Cost of Illness
1
2015
254
0.110
Why?
Multicenter Studies as Topic
1
2014
250
0.110
Why?
Metabolic Diseases
1
2014
98
0.110
Why?
Aged, 80 and over
3
2019
6357
0.110
Why?
Oxygen Consumption
4
2016
588
0.110
Why?
C-Reactive Protein
1
2015
363
0.110
Why?
Fatty Acids, Monounsaturated
1
2012
47
0.100
Why?
Prospective Studies
3
2019
6232
0.100
Why?
Mitochondria
1
2018
750
0.100
Why?
Homeostasis
1
2016
578
0.100
Why?
Depressive Disorder, Major
1
2015
302
0.100
Why?
Models, Theoretical
1
2016
517
0.100
Why?
Adult Children
1
2011
21
0.100
Why?
Practice Guidelines as Topic
1
2019
1398
0.100
Why?
Age Factors
1
2018
2894
0.090
Why?
Placebos
2
2009
198
0.090
Why?
Diabetes, Gestational
1
2015
281
0.090
Why?
Adipocytes
1
2012
189
0.090
Why?
Metabolomics
1
2015
527
0.090
Why?
Health Behavior
2
2023
704
0.090
Why?
Quality of Life
3
2019
2359
0.090
Why?
Comorbidity
1
2015
1457
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2019
1184
0.090
Why?
Sitagliptin Phosphate
1
2010
30
0.090
Why?
Longevity
1
2011
137
0.090
Why?
Family Health
1
2011
194
0.090
Why?
Mitochondria, Muscle
2
2021
93
0.090
Why?
C-Peptide
1
2010
138
0.090
Why?
Tandem Mass Spectrometry
1
2012
413
0.080
Why?
Delphi Technique
2
2019
163
0.080
Why?
Menopause
1
2011
271
0.080
Why?
Leisure Activities
1
2008
25
0.080
Why?
Blood Pressure
1
2014
1539
0.080
Why?
Body Composition
1
2011
586
0.070
Why?
Postoperative Complications
1
1997
2150
0.070
Why?
Risk Assessment
3
2015
2976
0.070
Why?
Predictive Value of Tests
1
2012
1812
0.070
Why?
Mass Screening
1
2013
1012
0.070
Why?
Cohort Studies
4
2021
4904
0.070
Why?
Diabetes Mellitus, Type 1
2
2012
3245
0.070
Why?
Fibrinogen
2
2018
155
0.070
Why?
Multivariate Analysis
1
2009
1435
0.060
Why?
Aging
1
2015
1624
0.060
Why?
Regression Analysis
2
2019
948
0.060
Why?
Retrospective Studies
2
2019
12548
0.060
Why?
Incidence
3
2019
2318
0.060
Why?
Gene Expression Profiling
2
2023
1523
0.060
Why?
Prognosis
2
2023
3334
0.060
Why?
Health Expenditures
1
1986
171
0.060
Why?
Depression
1
2012
1136
0.060
Why?
Metabolic Clearance Rate
1
2004
106
0.060
Why?
Mice, Inbred C57BL
1
2013
4718
0.060
Why?
Alcohol Drinking
1
2009
655
0.060
Why?
Hormones
1
2004
132
0.060
Why?
Parents
1
2011
1190
0.060
Why?
Menstrual Cycle
1
2003
108
0.050
Why?
Eligibility Determination
1
2023
60
0.050
Why?
Wakefulness
2
2015
128
0.050
Why?
Lactic Acid
1
2003
278
0.050
Why?
Proportional Hazards Models
2
2017
1080
0.050
Why?
Disease Progression
2
2019
2389
0.050
Why?
Citric Acid Cycle
1
2021
43
0.050
Why?
Subcellular Fractions
1
2021
78
0.050
Why?
Injections, Subcutaneous
1
2021
133
0.050
Why?
Sex Hormone-Binding Globulin
1
2020
48
0.050
Why?
Kinetics
1
2004
1558
0.050
Why?
Motor Activity
2
2015
642
0.050
Why?
Protective Agents
1
2020
38
0.040
Why?
Education
1
2020
95
0.040
Why?
Pregnancy
2
2015
5520
0.040
Why?
Proprotein Convertase 9
1
2020
61
0.040
Why?
Stearoyl-CoA Desaturase
2
2010
53
0.040
Why?
Time Factors
3
2019
6141
0.040
Why?
Poisson Distribution
1
2019
72
0.040
Why?
Analysis of Variance
2
2013
1229
0.040
Why?
Stakeholder Participation
1
2019
73
0.040
Why?
E-Selectin
1
2018
53
0.040
Why?
Consensus Development Conferences as Topic
1
2018
28
0.040
Why?
Subcutaneous Fat
1
2019
71
0.040
Why?
Chemokine CCL2
1
2018
105
0.040
Why?
Probability
1
2019
289
0.040
Why?
Primary Cell Culture
1
2019
149
0.040
Why?
Intra-Abdominal Fat
1
2019
83
0.040
Why?
Intercellular Adhesion Molecule-1
1
2018
154
0.040
Why?
Cell Nucleus
1
2020
556
0.040
Why?
Diet
3
2012
1076
0.040
Why?
Research
1
2020
395
0.040
Why?
Leptin
1
2018
211
0.040
Why?
Case-Control Studies
2
2017
3015
0.040
Why?
Adaptation, Physiological
2
2010
481
0.030
Why?
Metabolome
1
2019
285
0.030
Why?
Sequence Analysis, RNA
1
2019
387
0.030
Why?
Biological Transport
1
2017
372
0.030
Why?
Longitudinal Studies
2
2013
2389
0.030
Why?
Fatty Acids, Unsaturated
1
2016
85
0.030
Why?
Diet, Fat-Restricted
1
2015
73
0.030
Why?
Blood Glucose Self-Monitoring
1
2020
497
0.030
Why?
Kidney
1
2022
1186
0.030
Why?
Melatonin
1
2015
105
0.030
Why?
Interleukin-6
1
2018
676
0.030
Why?
Fatty Acids
1
2016
385
0.030
Why?
Calorimetry
1
2013
61
0.030
Why?
Insulin Receptor Substrate Proteins
1
2012
56
0.030
Why?
Algorithms
1
2020
1489
0.030
Why?
Risk
1
2015
815
0.030
Why?
Glycerol
1
2012
84
0.030
Why?
Sleep Wake Disorders
1
2015
232
0.030
Why?
RNA, Messenger
2
2010
2563
0.030
Why?
Animals
1
2013
31867
0.020
Why?
Surveys and Questionnaires
1
2022
4631
0.020
Why?
Antidepressive Agents
1
2012
195
0.020
Why?
Calorimetry, Indirect
1
2010
70
0.020
Why?
Genetic Variation
1
2015
876
0.020
Why?
Palmitic Acid
1
2010
36
0.020
Why?
Polysomnography
1
2010
135
0.020
Why?
Nicotine
1
2012
266
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
358
0.020
Why?
Gene Expression Regulation
1
2019
2329
0.020
Why?
Retinoid X Receptor gamma
1
2009
4
0.020
Why?
PPAR alpha
1
2009
52
0.020
Why?
Bicycling
1
2010
84
0.020
Why?
Women's Health
1
2011
271
0.020
Why?
Coronary Disease
1
2011
347
0.020
Why?
Phospholipids
1
2010
199
0.020
Why?
Phosphorylation
1
2012
1572
0.020
Why?
Reference Values
1
2009
748
0.020
Why?
Genetic Predisposition to Disease
1
2015
2108
0.020
Why?
Adiposity
1
2012
466
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
928
0.020
Why?
Patient Education as Topic
1
2011
682
0.020
Why?
Genotype
1
2011
1780
0.020
Why?
Infant Care
1
1986
42
0.020
Why?
Infertility
1
1986
45
0.020
Why?
Health Promotion
1
2011
686
0.020
Why?
Delivery, Obstetric
1
1986
118
0.020
Why?
Maternal Health Services
1
1986
78
0.010
Why?
Abortion, Induced
1
1986
71
0.010
Why?
Contraception
1
1986
117
0.010
Why?
Follicular Phase
1
2003
36
0.010
Why?
Anaerobic Threshold
1
2003
22
0.010
Why?
Spectrophotometry, Ultraviolet
1
2003
74
0.010
Why?
Luteal Phase
1
2003
41
0.010
Why?
Polymorphism, Single Nucleotide
1
2011
1901
0.010
Why?
Catecholamines
1
2003
96
0.010
Why?
Heart Rate
1
2003
705
0.010
Why?
Infant, Newborn
1
1986
5040
0.010
Why?
Perreault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)